Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Invitae's Q1 Revenue Soared 61%

TheMotleyFool

0 0

Here's Why Invitae's Q1 Revenue Soared 61%Photo, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Invitae's (NYSE: NVTA) winning ways in 2020 have gone by the wayside so far in 2021. Shares of the medical genetics company are down more than 25% year to date.

The company announced its first-quarter results after the market closed Tuesday. Invitae's downtrend appears likely to continue with the healthcare stock slipping nearly 3% in after-hours trading. Here are the highlights from the company's Q1 update.

Image source: Getty Images.

Source Fool.com

Like: 0

NVTA

Share